ScholarIQanswers from OpenAlex

Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure

PaperCitations, authors & open-access status

Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure have?

ScholarIQcitation count

Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure has 134 citations in the OpenAlex counts ScholarIQ stores.

When was Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure published?

ScholarIQyear

Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure has 2024 year in the ScholarIQ index.

What is the open-access status of Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure?

ScholarIQoa status

Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure has closed oa status in the ScholarIQ index.

What is the DOI of Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure?

ScholarIQdoi

The DOI for Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure is on the source record.

What is the PMID of Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure?

ScholarIQpmid

The PMID for Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure is on the source record.

What is the OpenAlex record for Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure?

ScholarIQopenalex

The OpenAlex for Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial